Monographie - Thiopental sodium

Última actualização :
28/04/2024

Thiopental sodium

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Anapental	Egipto
Anental	Colômbia, Venezuela
Epental	Arábia Saudita
Exipental	Irã
Farmotal	Itália
Gabapentax	Colômbia
Hipnopento	Argentina
Nesdonal	Países Baixos
Pantul	Equator, Peru
Pensodital	México
Pental	Turquia
Pentarim	México
Pentax	Venezuela
Pentocur	Islandia, Noruega
Pentotex	Malásia
Pentothal	Australia, Bélgica, Canadá, Dinamarca, Finlandia, Grècia, Itália, Luxemburgo, México, Suècia, Suicia
Sodipental	Colômbia, México
Thiojex	Chilli
Thiomek	Peru
Thiopental	Alemanha, Arábia Saudita, Austria, Egipto, França, Gran-bretanha, Grècia, Hungria, Irã, Irlanda, Malásia, Marrocos, Polonia, Romènia, Tunísia
Thiopentax	Equator, Venezuela
Tiobarbital	Colômbia, Espanha
Trapanal	Alemanha
Zedisol	México

Bibliografía : Thiopental sodium

	Tipo	Publicação
59	Jornal	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
125	Jornal	Chernin EL, Stewart JT, Smiler B. Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C. Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
126	Jornal	Prankerd RJ, Jones RD. Physicochemical compatibility of propofol with thiopental sodium. Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
299	Jornal	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
314	Jornal	Chiu MF, Schwartz ML. Visual compatibility of injectable drugs used in the intensive care unit. Am J Health-Syst Pharm 1997 ; 54: 64-65.
319	Jornal	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
350	Jornal	Martens HJ, De Goede PN, Van Loenen AC. Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers. Am J Hosp Pharm 1990 ; 47: 369-373.
527	Jornal	Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR. Chemical stability of thiopental sodium injection in disposable plastic syringes. J Clin Pharm Ther 1987 ; 12: 339-342.
642	Jornal	Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA. Norepinephrine stability in saline solutions. Hosp Pharm 1988 ; 23: 44,49, 59.
755	Laboratório	Pancuronium (Pavulon®) - Résumé des caractéristiques du produit MSD France 2016
871	Jornal	Haws JL, Herman N, Clark Y, Bjoraker R, Jones D. The chemical stability and sterility of sodium thiopental after preparation. Anesth Analg 1998 ; 86: 208-213.
919	Jornal	Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS. Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg 1998 ; 86: 422-426.
1173	Jornal	Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. Interactions between drugs and polyvinyl chloride infusion bags. Am J Hosp Pharm 1981 ; 38: 1308-1314.
1713	Jornal	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	Jornal	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	Jornal	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
2073	Jornal	Taniguchi T, Yamamoto K, Kobayashi T. Precipitate formed by thiopentone and vecuronium causes pulmonary embolism. Can J Anesth 1998 ; 45: 347-351.
2079	Jornal	Morton WD, Lerman J. The effect of pancuronium on the solubility of aqueous thiopentone. Can J Anesth 1987 ; 34: 87-89.
2090	Jornal	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2105	Jornal	Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C. Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo. Farm Hosp 1999 ; 23: 357-360.
2146	Jornal	Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2231	Jornal	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3134	Jornal	Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM. Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. Enferm Intensiva 2010 ; 21: 96-103.
3212	Jornal	Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos. Enferm Intensiva 2011 ;22:78-82.
3372	Jornal	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3373	Jornal	Khan S, Stannard N, Greijn J. Precipitation of thiopental with muscle relaxants: a potential hazard. J R Soc Med Sh Rep 2011 ; 2: 58.
3377	Jornal	Huddy NC, Durcan JJ. Precipitation betwen meptazinol and thiopentone. Anaesthesia 1983 ; 38: 601-602.
3408	Jornal	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3464	Jornal	Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau. Compatibilidad física de la amiodarona en perfusión continua Enferm Clin 2011 21:25-29.
3466	Jornal	B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos Enferm Intensiva 2011 ;22:78-82.
3501	Laboratório	Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics Pfizer 2011
3503	Laboratório	Fentanyl - Summary of product Characteristics Hameln Pharmaceuticals 2012
3525	Laboratório	Pethidine hydrochloride - Summary of product Characteristics AMCO Amdipharm Mercury 2012
3526	Laboratório	Clindamycin (Dalacin®) - Summary of Product Characteristics Pharmacia 2010
3531	Laboratório	Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics Wockhardt 2014
3549	Laboratório	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3564	Laboratório	Rocuronium B Braun - Résumé des caractéristiques du produit. B Braun 2012
3599	Laboratório	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3600	Laboratório	Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit UCB Pharma SA 2009
3601	Laboratório	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
3607	Laboratório	Esmolol hydrochloride for injection - Summary of Product Characteristics AOP Orphan Pharmaceuticals AG 2013
3612	Laboratório	Doxapram (Dopram) - Summary of Product Characteristics Amdipharm Mercury Company 2012
3614	Laboratório	Nicardipine Injection - Summary of Product Characteristics American Regent Inc 2013
3629	Laboratório	Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics Actavis UK 2014
3630	Laboratório	Vecuronium (Norcuron®) - Summary of Product Characteristics Merck Sharp Dohme 2012
3631	Laboratório	Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit Aguettant 2016
3674	Laboratório	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3675	Laboratório	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3676	Laboratório	Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit Hospira 2014
3767	Jornal	Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : 167-172.
3823	Jornal	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3932	Laboratório	Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 2015
3941	Laboratório	Nicardipine - Summary of Product Characteristics Concordia International 2017
4009	Laboratório	Droperidol - Résumé des Caractéristiques du Produit Panpharma 2017
4428	Jornal	Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4700	Laboratório	Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics AS Kalceks 2022

Mentions Légales